Search Results 181-190 of 19018 for Chronic Lymphocytic Leukemia
Slager, Ph.D., is researching chronic lymphocytic leukemia (CLL), a cancer of the blood. She has requested samples from 824 Biobank participants without a ...
A Study of Acalabrutinib Plus Venetoclax Versus Venetoclax Plus Obinutuzumab in Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma.
Research. Mayo Clinic physicians collaborate on leukemia care. Mayo Clinic doctors and researchers are studying the latest in diagnosis and treatment of acute ...
The Slager B-Cell Lymphoproliferative Disorders Lab at Mayo Clinic studies the genetic epidemiology of chronic lymphocytic leukemia (CLL), monoclonal B-cell ...
... (chronic) exercise on immune characteristics and function (phenotype) of patients with indolent non-Hodgkin lymphoma (NHL) and chronic lymphocytic leukemia (CLL) ...
A Study to Evaluate Daratumumab and Ibrutinib to Treat Relapsed / Refractory Chronic Lymphocytic Leukemia Treatment (DIRECT). Print details. Share; Facebook ...
The purpose of this study is to determine the effectiveness and safety of JCAR017 in adult subjects with relapsed or refractory Chronic Lymphocytic Leukemia ( ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.